Key result
Prediabetes-range fasting glucose trajectories linked to ~102% higher atherosclerosis risk versus normal glucose regulation.
Why the study?
Does long-term elevation of fasting blood glucose increase the risk of atherosclerosis in a health check-up population?
Cohort (n=2,583)
No
Does long-term elevation of fasting blood glucose increase the risk of atherosclerosis in a health check-up population?
Long-term elevation of fasting blood glucose, even at levels below the international prediabetes threshold, is significantly associated with increased atherosclerosis risk, highlighting the need for population-specific thresholds.
Answers are grounded in this paper and cite their sources.
May warrant closer FBG trajectory monitoring; leaves open whether population-specific thresholds improve outcomes.
BACKGROUND: Atherosclerosis, the primary pathological basis of cardiovascular diseases, exhibits a strong association with glucose metabolism dysregulation. While cross-sectional studies have linked fasting blood glucose (FBG) to atherosclerosis risk, the dose-response relationship and threshold characteristics of long-term FBG trajectories remain poorly characterized. This retrospective cohort study aimed to investigate longitudinal FBG trajectory patterns and their associations with atherosclerosis risk prevalence, incidence, and recovery in Chongqing, China, while also identifying population-specific risk thresholds. METHODS: Based on the three-year longitudinal follow-up data collected annually from 2017 to 2019, a population-based trajectory model (GBTM) was adopted to identify the dynamic trajectory of FBG. The association between FBG and atherosclerosis risk was analyzed using multivariable logistic regression. Restricted cubic splines (RCS) were used to assess the non-linear relationship between FBG and atherosclerosis risk and to determine risk thresholds. Confounding factors such as age, sex, body mass index (BMI), blood pressure, and lipids were adjusted for in the regression models, and subgroup analyses were performed to examine the interactions of age, sex, and BMI. RESULTS: Longitudinal analysis showed that compared with the Trajectory Normal Glucose Regulation (NGR) group, the Trajectory Prediabetes Mellitus group (Pre-DM) group had significantly higher prevalence (OR: 2.02, 95% CI: 1.63-2.51) and incidence (OR: 1.66, 95% CI: 1.15-2.39) of atherosclerosis risk. The Trajectory Pre-DM group also had a significantly lower likelihood of atherosclerosis risk recovery than the Trajectory NGR group (OR: 0.55, 95% CI: 0.39-0.79). Dose-response analysis revealed a non-linear association between FBG and atherosclerosis risk prevalence, with a risk threshold at 5.10 mmol/L. This suggests that the atherosclerosis risk threshold in Chongqing is significantly lower than the international prediabetes standard of 5.60 mmol/L. Subgroup analyses showed sex and age differences, with lower thresholds in women and younger individuals. CONCLUSIONS: Long-term elevation of FBG was associated with increased atherosclerosis risk. The study suggests that intervention strategies should be based on dynamic blood glucose trajectories and population-specific thresholds, especially lower thresholds for women and younger individuals. This study provides evidence-based support for regional atherosclerosis risk prevention and control.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Atherosclerosis risk (n=2,583). Prediabetes mellitus fasting blood glucose trajectory vs. Normal glucose regulation trajectory was evaluated on Prevalence of atherosclerosis risk (defined as atherogenic index of plasma ≥ 0.1) (OR 2.02, 95% CI 1.63-2.51, p=<0.001). Long-term fasting blood glucose trajectories in the prediabetes range were associated with a higher prevalence of atherosclerosis risk compared to normal glucose regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: